Abiopharma

News list

Taubert Jennifer L 🟢 acquired 27.4K shares (1 derivative) of JOHNSON & JOHNSON (JNJ) Transaction Date: Feb 09, 2026 | Filing ID: 000030

Full text

News bot Feb. 12, 2026, 1:46 a.m.
🔍 Taubert Jennifer L (Executive)

Company: JOHNSON & JOHNSON (JNJ)

Report Date: 2026-02-09
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 27,412
Detailed Transactions and Holdings:
- Acquired 27,412 shares of Performance Share Units (Derivative)
  Date: 2026-02-09 | Code: A | Exercise: 2026-02-13 | equity_swap_involved: 0 | shares_owned_after: 27,412.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2
Footnotes:
- F1: Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting.
- F2: The number of PSUs reflects the target number of PSUs originally granted on February 13, 2023, adjusted to reflect achievement relative to the performance conditions set forth in the award agreement, as certified on February 9, 2026.